Journal Logo

Simultaneous Sessions IV: Gene therapy, cellular immunotherapy and vaccination – Clinical

S1635 ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA

Del Bufalo, F.1; Merli, P.1; Vinti, L.1; Algeri, M.1; Cefalo, M.G.1; Bertaina, V.1; Li Pira, G.1; Caruana, I.1; De Angelis, B.1; Boffa, I.1; De Cecca, S.1; Orlando, D.1; Guercio, M.1; Sinibaldi, M.1; Abbaszadeh, Z.1; Polito, V.A.1; Cristantielli, R.1; Quintarelli, C.1; Locatelli, F.1

Author Information
doi: 10.1097/01.HS9.0000564788.37982.52
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.